Glycine and its synaptic interactions: Functional and clinical implications

Neurology

Volumn 77, Issue 7, 2011, Pages 677-683

  Benarroch, Eduardo E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GEPHYRIN; GLUTAMIC ACID; GLYCINE; GLYCINE TRANSPORTER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ALLOSTERISM; AUTOIMMUNE DISEASE; CELLULAR DISTRIBUTION; HUMAN; HYPEREKPLEXIA; HYPERGLYCINEMIA; MOTONEURON; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SCHIZOPHRENIA; SPINAL CORD DORSAL HORN; SYNAPTIC POTENTIAL; ANIMAL; ARTICLE; PHYSIOLOGY; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALS; GLYCINE; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 80055079419     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31822a2791     Document Type: Review

References (56)

1. Legendre P. The glycinergic inhibitory synapse. Cell Mol Life Sci 2001;58:760-793. (Pubitemid 32553033)
2. Betz H, Gomeza J, Armsen W, Scholze P, Eulenburg V. Glycine transporters: essential regulators of synaptic transmission. Biochem Soc Trans 2006;34:55-58. (Pubitemid 43235533)
3. Zafra F, Gimenez C. Glycine transporters and synaptic function. IUBMB Life 2008;60:810-817.
4. Betz H, Laube B. Glycine receptors: recent insights into their structural organization and functional diversity. J Neurochem 2006;97:1600-1610. (Pubitemid 43873655)
5. Lynch JW. Native glycine receptor subtypes and their physiological roles. Neuropharmacology 2009;56:303-309.
6. Dresbach T, Nawrotzki R, Kremer T, et al. Molecular architecture of glycinergic synapses. Histochem Cell Biol 2008;130:617-633.
7. Fritschy JM, Harvey RJ, Schwarz G. Gephyrin: where do we stand, where do we go? Trends Neurosci 2008;31:257-264.
8. Kikuchi G, Motokawa Y, Yoshida T, Hiraga K. Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia. Proc Jpn Acad Ser B Phys Biol Sci 2008;84:246-263.
9. Davies JS, Chung SK, Thomas RH, et al. The glycinergic system in human startle disease: a genetic screening approach. Front Mol Neurosci 2010;3:8.
10. Sagne C, El Mestikawy S, Isambert MF, et al. Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. FEBS Lett 1997;417:177-183. (Pubitemid 27491728)
11. Chaudhry FA, Reimer RJ, Bellocchio EE, et al. The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J Neurosci 1998;18:9733-9750. (Pubitemid 28543754)
12. Wojcik SM, Katsurabayashi S, Guillemin I, et al. A shared vesicular carrier allows synaptic corelease of GABA and glycine. Neuron 2006;50:575-587.
13. Dugue GP, Dumoulin A, Triller A, Dieudonne S. Targetdependent use of co-released inhibitory transmitters at central synapses. J Neurosci 2005;25:6490-6498. (Pubitemid 40995281)
14. Todd AJ, Sullivan AC. Light microscope study of the coexistence of GABA-like and glycine-like immunoreactivities in the spinal cord of the rat. J Comp Neurol 1990;296: 496-505. (Pubitemid 20188821)
15. Gomeza J, Hulsmann S, Ohno K, et al. Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron 2003;40: 785-796. (Pubitemid 37431038)
16. Gomeza J, Ohno K, Hulsmann S, et al. Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 2003;40: 797-806. (Pubitemid 37431039)
17. Lopez-Corcuera B, Aragon C, Geerlings A. Regulation of glycine transporters. Biochem Soc Trans 2001;29:742-745. (Pubitemid 33131773)
18. Harvey K, Duguid IC, Alldred MJ, et al. The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. J Neurosci 2004;24:5816-5826. (Pubitemid 38857236)
19. Wang W, Xu TL. Chloride homeostasis differentially affects GABA(A) receptor- and glycine receptor-mediated effects on spontaneous circuit activity in hippocampal cell culture. Neurosci Lett 2006;406:11-16. (Pubitemid 44278369)
20. Taal W, Holstege JC. GABA and glycine frequently colocalize in terminals on cat spinal motoneurons. Neuroreport 1994;5:2225-2228. (Pubitemid 24374841)
21. Todd AJ, Watt C, Spike RC, Sieghart W. Colocalization of GABA, glycine, and their receptors at synapses in the rat spinal cord. J Neurosci 1996;16:974-982. (Pubitemid 26140853)
22. Rubio ME, Juiz JM. Differential distribution of synaptic endings containing glutamate, glycine, and GABA in the rat dorsal cochlear nucleus. J Comp Neurol 2004;477: 253-272. (Pubitemid 39129611)
23. Wentzel PR, De Zeeuw CI, Holstege JC, Gerrits NM. Colocalization of GABA and glycine in the rabbit oculomotor nucleus. Neurosci Lett 1993;164:25-29. (Pubitemid 24040672)
24. Ottersen OP, Storm-Mathisen J, Somogyi P. Colocalization of glycine-like and GABA-like immunoreactivities in Golgi cell terminals in the rat cerebellum: a postembedding light and electron microscopic study. Brain Res 1988; 450:342-353.
25. Waldvogel HJ, Baer K, Eady E, et al. Differential localization of gamma-aminobutyric acid type A and glycine receptor subunits and gephyrin in the human pons, medulla oblongata and uppermost cervical segment of the spinal cord: an immunohistochemical study. J Comp Neurol 2010;518:305-328.
26. Jonas P, Bischofberger J, Sandkuhler J. Corelease of two fast neurotransmitters at a central synapse. Science 1998; 281:419-424. (Pubitemid 28340787)
27. Russier M, Kopysova IL, Ankri N, Ferrand N, Debanne D. GABA and glycine co-release optimizes functional inhibition in rat brainstem motoneurons in vitro. J Physiol 2002;541:123-137. (Pubitemid 35190189)
28. Awatramani GB, Turecek R, Trussell LO. Staggered development of GABAergic and glycinergic transmission in the MNTB. J Neurophysiol 2005;93:819-828.
29. Nabekura J, Katsurabayashi S, Kakazu Y, et al. Developmental switch from GABA to glycine release in single central synaptic terminals. Nat Neurosci 2004;7:17-23. (Pubitemid 38032163)
30. Lu T, Rubio ME, Trussell LO. Glycinergic transmission shaped by the corelease of GABA in a mammalian auditory synapse. Neuron 2008;57:524-535. (Pubitemid 351273989)
31. Singer JH. GABA is an endogenous ligand for synaptic glycine receptors. Neuron 2008;57:475-477. (Pubitemid 351274001)
32. Rekling JC, Funk GD, Bayliss DA, Dong XW, Feldman JL. Synaptic control of motoneuronal excitability. Physiol Rev 2000;80:767-852. (Pubitemid 30164949)
33. Wang Z, Li L, Goulding M, Frank E. Early postnatal development of reciprocal Ia inhibition in the murine spinal cord. J Neurophysiol 2008;100:185-196.
34. Schneider SP, Fyffe RE. Involvement of GABA and glycine in recurrent inhibition of spinal motoneurons. J Neurophysiol 1992;68:397-406.
35. Chase MH. Confirmation of the consensus that glycinergic postsynaptic inhibition is responsible for the atonia of REM sleep. Sleep 2008;31:1487-1491.
36. Soja PJ. Glycine-mediated postsynaptic inhibition is responsible for REM sleep atonia. Sleep 2008;31:1483-1486.
37. Brooks PL, Peever JH. Glycinergic and GABA(A)- mediated inhibition of somatic motoneurons does not mediate rapid eye movement sleep motor atonia. J Neurosci 2008;28:3535-3545.
38. Chery N, de Koninck Y. Junctional versus extrajunctional glycine and GABA(A) receptor-mediated IPSCs in identified lamina I neurons of the adult rat spinal cord. J Neurosci 1999;19:7342-7355. (Pubitemid 29404591)
39. Zeilhofer HU. The glycinergic control of spinal pain processing. Cell Mol Life Sci 2005;62:2027-2035. (Pubitemid 41291660)
40. Takazawa T, MacDermott AB. Synaptic pathways and inhibitory gates in the spinal cord dorsal horn. Ann NY Acad Sci 2010;1198:153-158.
41. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987; 325:529-531. (Pubitemid 17056733)
42. Martina M, Gorfinkel Y, Halman S, et al. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J Physiol 2004;557: 489-500. (Pubitemid 38807389)
43. Tsai G, Ralph-Williams RJ, Martina M, et al. Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci USA 2004;101: 8485-8490. (Pubitemid 38736601)
44. Wolosker H, Dumin E, Balan L, Foltyn VN. D-amino acids in the brain: D-serine in neurotransmission and neurodegeneration. Febs J 2008;275:3514-3526.
45. Pina-Crespo JC, Talantova M, Micu I, et al. Excitatory glycine responses of CNS myelin mediated by NR1/NR3 "NMDA" receptor subunits. J Neurosci 2010;30:11501-11505.
46. Liu J, Wu DC, Wang YT. Allosteric potentiation of glycine receptor chloride currents by glutamate. Nat Neurosci 2010;13:1225-1232.
47. Suzuki Y, Kure S, Oota M, Hino H, Fukuda M. Nonketotic hyperglycinemia: proposal of a diagnostic and treatment strategy. Pediatr Neurol 2010;43:221-224.
48. Brunel-Guitton C, Casey B, Coulter-Mackie M, et al. Late-onset nonketotic hyperglycinemia caused by a novel homozygous missense mutation in the GLDC gene. Mol Genet Metab 2011;103:193-196.
49. Meyer S, Acquaviva C, Shamdeen MG, Haas D, Vianey- Saban C. A novel missense mutation in a neonate with nonketotic hyperglycinemia. Pediatr Neurol 2010;43: 363-367.
50. Meinck HM. Startle and its disorders. Neurophysiol Clin 2006;36:357-364.
51. Butler MH, Hayashi A, Ohkoshi N, et al. Autoimmunity to gephyrin in stiff-man syndrome. Neuron 2000;26:307-312.
52. Hutchinson M, Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 2008;71:1291-1292.
53. Coull JA, Boudreau D, Bachand K, et al. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 2003;424:938-942. (Pubitemid 37051684)
54. Miraucourt LS, Peirs C, Dallel R, Voisin DL. Glycine inhibitory dysfunction turns touch into pain through astrocyte-derived d-serine. Pain 2011;152:1340-1348.
55. Sur C, Kinney GG. Glycine transporter 1 inhibitors and modulation of NMDA receptor-mediated excitatory neurotransmission. Curr Drug Targets 2007;8:643-649. (Pubitemid 46785062)
56. Javitt DC. Glycine transport inhibitors and the treatment of schizophrenia. Biol Psychiatry 2008;63:6-8. (Pubitemid 350234898)